Is concomitant use of varenicline with nicotine replacement therapy recommended?

• A. Yes
• B. Not studied
• C. No
• D. Only with monitoring

Answer: (C)

The key idea tested is how to safely use pharmacotherapy options for nicotine dependence when another agent is already in use. Varenicline is a high-affinity partial agonist at the alpha4beta2 nicotinic receptor, which helps reduce withdrawal while blocking nicotine’s rewarding effect. Because there isn’t strong evidence showing added benefit from combining varenicline with nicotine replacement therapy (NRT) and because concurrent nicotine exposure could increase adverse effects or complicate the treatment response, the standard recommendation is not to use them together. That’s why the best choice is that concomitant use is not recommended.

In cases where a patient still experiences cravings or withdrawal symptoms, clinicians may consider alternative strategies rather than adding NRT to varenicline, since the data do not robustly support concurrent use.